PAVmed (PAVM) Shareholder's Equity (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.30 Mn |
| Sep 30, 2025 | 32.52 Mn |
| Jun 30, 2025 | 28.16 Mn |
| Mar 31, 2025 | 38.93 Mn |
| Dec 31, 2024 | -2.50 Mn |
| Sep 10, 2024 | 9.16 Mn |
| Jun 30, 2024 | -18.64 Mn |
| Mar 31, 2024 | -20.58 Mn |
| Dec 31, 2023 | -24.02 Mn |
| Sep 30, 2023 | -15.83 Mn |
| Jun 30, 2023 | -830,000.00 |
| Mar 31, 2023 | 10.80 Mn |
| Dec 31, 2022 | 10.93 Mn |
| Sep 30, 2022 | 28.56 Mn |
| Jun 30, 2022 | 41.40 Mn |
| Mar 31, 2022 | 64.73 Mn |
| Dec 31, 2021 | 79.42 Mn |
| Sep 30, 2021 | 35.23 Mn |
| Jun 30, 2021 | 42.04 Mn |
| Mar 31, 2021 | 48.04 Mn |
| Dec 31, 2020 | -473,000.00 |
| Sep 30, 2020 | -14.76 Mn |
| Jun 30, 2020 | -12.81 Mn |
| Mar 31, 2020 | -16.23 Mn |
| Dec 31, 2019 | -4.64 Mn |
| Sep 30, 2019 | -2.41 Mn |
| Jun 30, 2019 | -1.88 Mn |
| Mar 31, 2019 | -5.67 Mn |
| Dec 31, 2018 | -2.48 Mn |
| Sep 30, 2018 | 3.56 Mn |
| Jun 30, 2018 | 6.52 Mn |
| Mar 31, 2018 | 247,836.00 |
| Dec 31, 2017 | -2.85 Mn |
| Sep 30, 2017 | -5.91 Mn |
| Jun 30, 2017 | -5.05 Mn |
| Mar 31, 2017 | -4.31 Mn |
| Dec 31, 2016 | -319,067.00 |
| Sep 30, 2016 | 1.14 Mn |
| Jun 30, 2016 | 2.75 Mn |
| Dec 31, 2015 | 633,918.00 |